Search Within

Salma H Afifi

Formats
  1. Journal Article (5)
  2. Meeting Abstract (3)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Myeloma (7)
  5. Hematologic Malignancies Research (5)
  6. Biostatistics Service (4)

More Groups

People
  1. Carl Landgren (4)
  2. Nelly Adel (4)
  3. Nikoletta Lendvai (4)
  4. Alexander Lesokhin (3)
  5. Hani Hassoun (3)
  6. Sean Devlin (3)

More People

Years
  1. 2020 (1)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (2)
  5. 2014 (2)
  6. 2013 (1)
Publications
  1. Blood (3)
  2. Annals of Pharmacotherapy (1)
  3. Bone Marrow Transplantation (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. JAMA Oncology (1)
  6. Pharmacotherapy (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. American Medical Association (1)
  3. Elsevier Inc. (1)
  4. John Wiley & Sons (1)
  5. Nature Publishing Group (1)
  6. Sage Publications (1)

More Publishers

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vitiligo following autologous hematopoietic stem cell transplantation
    Journal Article

    Nguyen, J.; Singh, N.; Afifi, S.; Giralt, S.; Lacouture, M. E.; Busam, K. J.; Hassoun, H.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • The rising price of cancer drugs - A new old problem?
    Journal Article

    Prasad, V.; Wang, R.; Afifi, S. H.; Mailankody, S.
    JAMA Oncology (2017)

    Fulltext@MSK | Save
  • Immunotherapy: A new approach to treating multiple myeloma with daratumumab and elotuzumab
    Journal Article

    Afifi, S.; Michael, A.; Lesokhin, A.
    Annals of Pharmacotherapy (2016)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study
    Journal Article

    Afifi, S.; Adel, N. G.; Devlin, S.; Duck, E.; Vanak, J.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Korde, N.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Incidence and management of proteasome inhibitor-related cardiotoxicity in multiple myeloma patients at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Land, J.; Afifi, S.; Adel, N. G.; Devlin, S.; Arora, A.; Lendvai, N.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save
  • Role of histone deacetylase inhibitors in relapsed refractory multiple myeloma: A focus on vorinostat and panobinostat
    Journal Article

    Afifi, S.; Michael, A.; Azimi, M.; Rodriguez, M.; Lendvai, N.; Landgren, O.
    Pharmacotherapy (2015)

    Fulltext@MSK | Save
  • Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients: An update on cost analysis study at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Duck, E.; Devlin, S. M.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Chung, D. J.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Cancer pharmacology
    Book Section

    Rodriguez, M.; Michael, A. G.; Seyboth, B. M.; Afifi, S.; Beyer, K.; Dang, T. O.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Impact of renal insufficiency and obesity on safety and outcomes of BEAM conditioning
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Zhang, Z.; Shi, W.; Moskowitz, C. H.; Matasar, M. J.
    Blood (2013)

    Fulltext@MSK | Save